4 ms·
From the article: “McKinsey started as a business that sold candid, dispassionate advice to corporate managers, but selling advice and building a brand around i
by danmostudco 6y ago
From the article: “McKinsey started as a business that sold candid, dispassionate advice to corporate managers, but selling advice and building a brand around it also sets up a mechanism for diffusing responsibility. The managers can say they’re just following the best available advice, and the consultants can say they’re just trying to help their clients boost profits and efficiency.“
I spent some time with an Engagement Manager at McKinsey a few years ago, and he noted one function that they provide to executives is a seemingly neutral arbiter for tough decisions that may be politically untenable inside an organization. A CEO may know exactly what drastic steps they need to take, but will face internal executive strife, board pressure, or lack of buy-in from the business to execute. McKinsey provides credibility in cases of extreme actions (layoffs, re-orgs, shutting down business functions, etc), which is why the final deliverable of an engagement will often times simply state what was already known across the organization, but in a more packaged, compelling format. The same Engagement Manager then noted that if management doesn’t know exactly the “answer” is to the question they are asking, often times the McKinsey Partner supervising the case has seen the problem enough times to generally know the solution they will recommend out of the gate, as they specialize in industries. Their team arrives and then spends the cycles putting together justification for their upcoming recommendation.
It seemed to me similar to the old adage “nobody gets fired for buying IBM,” executives can lean on the good will of the McKinsey brand to justify and expedite certain tricky decisions. In many cases this is about providing confidence to move in a certain direction. This has two benefits: the broader organization can be told an outside firm was able to arrive at said battle plan - ideally increasing buy-in since the “experts” recommended it, and if things go awry the executive can point to the deliverable handed off by the consultants as the sanctioned playbook. So this “diffusing responsibility” is a feature, not a bug.
I’ve seen two solutions to some of the implicit problems described above, neither or which are cheap or easy: either A) the management team is solid enough and garnered enough goodwill that they can navigate such troubled waters (hard to do as the business scales) or B) An organization gets large enough they can fund their own internal management consulting team to tackle tough problems on a case by case basis - Samsung has used this across their business lines.
- cushychicken 6y ago“diffusing responsibility” is a feature, not a bug. Another way I've heard this said is: "McKinsey doesn't typically sell you the plan for the hard change - they sell you the credibility to act on it."
- coredog64 6y agoThe pithy version of this is “Paying McKinsey to look at your watch and tell you the time.”
- cushychicken 6y agoI like this one better XD
- rmrfstar 6y agoGDP growth comes from productivity growth. Productivity growth comes from research and development. Michael Pearson [1], a 23 year McKinsey veteran pharma CEO, claimed that R&D was "inefficient". It is just mind blowing that people see this and don't panic. We are allowing ourselves to be ruled by mediocre spreadsheet jockeys. [1] https://en.wikipedia.org/wiki/J._Michael_Pearson https://en.wikipedia.org/wiki/J._Michael_Pearson [2] https://dealbook.nytimes.com/2013/09/02/in-a-new-book-mckinsey-co-isnt-all-roses/ https://dealbook.nytimes.com/2013/09/02/in-a-new-book-mckins...
- pbk1 6y agoPeople didn't "panic", but the markets and industry did certainly react to his ideas and behavior - the pharma company he ran (Valeant) tanked and he was ousted as CEO.
- rmrfstar 6y agoThey reacted to his public acknowledgement of private policy, not the policy itself. He was just parroting this McKinsey memo from 2010 [1]. R&D in the United States is dangerously neglected. [1] https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/new-frontiers-in-pharma-r-and-38d-investment https://www.mckinsey.com/industries/pharmaceuticals-and-medi...